CA2155518A1 - Compositions pharmaceutiques renfermant une matiere spongieuse constituee d'esters d'acide hyarulonique, combines avec d'autres substances actives en pharmacologie - Google Patents
Compositions pharmaceutiques renfermant une matiere spongieuse constituee d'esters d'acide hyarulonique, combines avec d'autres substances actives en pharmacologieInfo
- Publication number
- CA2155518A1 CA2155518A1 CA002155518A CA2155518A CA2155518A1 CA 2155518 A1 CA2155518 A1 CA 2155518A1 CA 002155518 A CA002155518 A CA 002155518A CA 2155518 A CA2155518 A CA 2155518A CA 2155518 A1 CA2155518 A1 CA 2155518A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical compositions
- solution
- hrs
- hyaluronic acid
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 30
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 17
- 239000013543 active substance Substances 0.000 title abstract description 6
- 239000002253 acid Substances 0.000 title description 3
- 150000002148 esters Chemical class 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 33
- -1 ester derivatives of hyaluronic acid Chemical class 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000002406 microsurgery Methods 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 7
- 238000001356 surgical procedure Methods 0.000 claims abstract description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 29
- 229960003160 hyaluronic acid Drugs 0.000 claims description 29
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 230000008439 repair process Effects 0.000 claims description 19
- 210000003454 tympanic membrane Anatomy 0.000 claims description 19
- 239000012528 membrane Substances 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002831 pharmacologic agent Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 230000003902 lesion Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000015271 coagulation Effects 0.000 claims description 5
- 238000005345 coagulation Methods 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 230000007928 solubilization Effects 0.000 claims description 5
- 238000005063 solubilization Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 239000004014 plasticizer Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000002316 cosmetic surgery Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 238000002278 reconstructive surgery Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000000859 sublimation Methods 0.000 claims description 3
- 230000008022 sublimation Effects 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000005213 imbibition Methods 0.000 claims description 2
- 230000002980 postoperative effect Effects 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000001857 anti-mycotic effect Effects 0.000 claims 1
- 239000002543 antimycotic Substances 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 29
- 241000700159 Rattus Species 0.000 description 12
- 239000000047 product Substances 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 3
- 241000722985 Fidia Species 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 206010045210 Tympanic Membrane Perforation Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229960001334 corticosteroids Drugs 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010066054 Dysmorphism Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000037313 granulation tissue formation Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000012454 limulus amebocyte lysate test Methods 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI93A000182 | 1993-02-04 | ||
| ITMI930182A IT1263144B (it) | 1993-02-04 | 1993-02-04 | Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive |
| PCT/EP1994/000294 WO1994017840A1 (fr) | 1993-02-04 | 1994-02-02 | Compositions pharmaceutiques comprenant une substance spongieuse composee de derives ester d'acide hyaluronique en combinaison avec d'autres substances pharmacologiquement actives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2155518A1 true CA2155518A1 (fr) | 1994-08-18 |
Family
ID=11364858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002155518A Abandoned CA2155518A1 (fr) | 1993-02-04 | 1994-02-02 | Compositions pharmaceutiques renfermant une matiere spongieuse constituee d'esters d'acide hyarulonique, combines avec d'autres substances actives en pharmacologie |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0682534A1 (fr) |
| JP (1) | JPH08506497A (fr) |
| KR (1) | KR960700766A (fr) |
| AU (1) | AU6001494A (fr) |
| CA (1) | CA2155518A1 (fr) |
| IT (1) | IT1263144B (fr) |
| WO (1) | WO1994017840A1 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997045532A1 (fr) * | 1996-05-28 | 1997-12-04 | Brown University Research Foundation | Charpentes biodegradables a base de hyaluronan destinees a la reparation tissulaire |
| US6596703B1 (en) | 1997-07-11 | 2003-07-22 | Jagotec Ag | Promotion of wound healing utilizing steroids having reduced deteriorous systemic side effects typical of glucocorticoids, mineralocorticoids and sex steroids |
| US6872819B1 (en) * | 1998-05-27 | 2005-03-29 | Fidia Advanced Biopolymers S.R.L. | Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells |
| WO2002045767A1 (fr) * | 2000-12-07 | 2002-06-13 | Japan Tissue Engineering Co.,Ltd | Substrat de regeneration de tissus, materiel de transplantation, et procedes de production de ces elements |
| JP4135502B2 (ja) | 2001-01-31 | 2008-08-20 | 生化学工業株式会社 | 架橋多糖スポンジ |
| US7238677B2 (en) * | 2003-03-28 | 2007-07-03 | Kimberly-Clark Worldwide, Inc. | Prevention of urogenital infections |
| US8021684B2 (en) * | 2004-07-09 | 2011-09-20 | Ferrosan Medical Devices A/S | Haemostatic composition comprising hyaluronic acid |
| JP4754532B2 (ja) * | 2007-07-09 | 2011-08-24 | 生化学工業株式会社 | ヒアルロン酸オリゴ糖を有効成分とする治療剤 |
| US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| CA2865349C (fr) | 2012-03-06 | 2021-07-06 | Ferrosan Medical Devices A/S | Recipient mis sous pression contenant de la pate hemostatique |
| EP2977066A3 (fr) | 2012-06-12 | 2016-07-27 | Ferrosan Medical Devices A/S | Composition hémostatique sèche |
| BR112015030612B1 (pt) | 2013-06-21 | 2020-07-21 | Ferrosan Medical Devices A/S | método para preparar uma composição seca |
| EP3470094B1 (fr) | 2013-12-11 | 2020-07-22 | Ferrosan Medical Devices A/S | Composition sèche comprenant un améliorateur d'extrusion |
| CA2960309A1 (fr) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Composition seche destinee a etre utilisee en hemostase et cicatrisation de plaie |
| RU2705905C2 (ru) | 2014-12-24 | 2019-11-12 | Ферросан Медикал Дивайсиз А/С | Шприц для удерживания и смешивания первого и второго веществ |
| CN107771093B (zh) | 2015-07-03 | 2021-06-15 | 弗罗桑医疗设备公司 | 用于混合两种组分和用于在存储条件下保持真空的注射器 |
| ES2968412T3 (es) | 2018-05-09 | 2024-05-09 | Ferrosan Medical Devices As | Método para preparar una composición hemostática |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (it) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| IT1248934B (it) * | 1990-06-01 | 1995-02-11 | Fidia Spa | Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle |
| IT1247472B (it) * | 1991-05-31 | 1994-12-17 | Fidia Spa | Processo per la preparazione di microsfere contenenti componenti biologicamente attivi. |
| IT1251151B (it) * | 1991-08-05 | 1995-05-04 | Fidia Spa | Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati |
| IT1260154B (it) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
-
1993
- 1993-02-04 IT ITMI930182A patent/IT1263144B/it active IP Right Grant
-
1994
- 1994-02-02 WO PCT/EP1994/000294 patent/WO1994017840A1/fr not_active Application Discontinuation
- 1994-02-02 CA CA002155518A patent/CA2155518A1/fr not_active Abandoned
- 1994-02-02 KR KR1019950703218A patent/KR960700766A/ko not_active Application Discontinuation
- 1994-02-02 EP EP94906201A patent/EP0682534A1/fr not_active Withdrawn
- 1994-02-02 AU AU60014/94A patent/AU6001494A/en not_active Abandoned
- 1994-02-02 JP JP6517622A patent/JPH08506497A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08506497A (ja) | 1996-07-16 |
| ITMI930182A1 (it) | 1994-08-04 |
| AU6001494A (en) | 1994-08-29 |
| IT1263144B (it) | 1996-08-01 |
| WO1994017840A1 (fr) | 1994-08-18 |
| KR960700766A (ko) | 1996-02-24 |
| ITMI930182A0 (it) | 1993-02-04 |
| EP0682534A1 (fr) | 1995-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5503848A (en) | Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery | |
| AU2002365662B2 (en) | Wound dressings | |
| CA2155518A1 (fr) | Compositions pharmaceutiques renfermant une matiere spongieuse constituee d'esters d'acide hyarulonique, combines avec d'autres substances actives en pharmacologie | |
| JP2007160092A (ja) | 酸化セルロースおよびヒト組換えコラーゲンを含有している創傷包帯 | |
| US20190151496A1 (en) | Novel active ingredient in cicatrization and use thereof | |
| CN106110369B (zh) | 一种医用复合型透明质酸敷料及其制备方法 | |
| KR20060134346A (ko) | 키토산계 미세다공성 폼 드레싱재 및 그 제조 방법 | |
| DE10041684A1 (de) | Beschichtungsmaterial zur medizinischen Behandlung aus resorbierbarem synthetischem Material, Verfahren zu seiner Herstellung und Verwendung in der Medizin | |
| DE69029969T2 (de) | Kunsthaut | |
| WO2007025729A2 (fr) | Corps moule permettant de traiter des blessures | |
| CN109966540B (zh) | 一种纳米甲壳素复合海藻酸钙医用敷料的制备方法及应用 | |
| RU2372944C2 (ru) | Покрытие для лечения ран | |
| KR100608192B1 (ko) | 창상 피복재 및 조직공학 구조체용 중화 키토산 스폰지제조방법 및 이에 의해 제조된 중화 키토산 스폰지 | |
| RU2370270C1 (ru) | Композиция для лечения ран | |
| KR100546793B1 (ko) | 키토산을 이용한 폼 드레싱재 및 이의 제조방법 | |
| Mao et al. | Nonwoven wound dressings | |
| US20130018334A1 (en) | Biodegradable wound care products with biocompatible artificial skin treatment and healing accelerator | |
| RU2240140C2 (ru) | Медицинская многослойная повязка и изделия на ее основе | |
| RU2108114C1 (ru) | Биологическая композиция для лечения ран "коллахит" | |
| DE102014211356A1 (de) | Wundkontaktmaterial zur Anwendung bei der Behandlung und/oder Versorgung von Wunden | |
| US20240285828A1 (en) | Composition using fibrotic acellular dermal matrix, and method for preparing same | |
| KR20050104704A (ko) | 키토산을 이용한 창상 피복재 및 이의 제조방법 | |
| EP1243260A1 (fr) | Pansement cicatrisant contenant de l' acide hyaluronique et du sulfate de chondroitine | |
| CN115554465A (zh) | 一种冻干可吸收胶原基医用敷料及其制备方法 | |
| DD291477A5 (de) | Verfahren zur herstellung eines biologisch aktiven materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |